Smiths Group plc engages in the development, manufacture, sale, and support of products and services for the threat and contraband detection, energy, medical devices, communications, and engineered components markets. Its detection technologies include X-ray, trace detection, and infrared and gamma ray spectroscopy, as well as millimetre-wave that detect and identify explosives, narcotics, weapons, chemical agents, biohazards, nuclear and radioactive materials, and contraband. The company’s engineered products comprise mechanical seals, seal support systems, engineered bearings, power transmission couplings, and specialist filtration systems for oil and gas, power generation, chemical, pharmaceutical, pulp and paper, and mining sectors. Its medical devices and consumables include medication delivery systems to treat cancer patients; vital care products to reduce hospital-acquired infections, manage patients’ airways, and maintain body temperature; and safety devices to prevent needlestick injuries and reduce cross-infection. The company also provides electronic and radio frequency products that connect, protect, and control critical systems for the wireless telecommunications, aerospace, defense, space, medical, rail, test, and industrial markets, as well as for data centers; and engineered components comprising ducting, hose assemblies, and heating elements that heat and move fluids and gases for the aerospace, medical, industrial, construction, and domestic appliance markets. It has operations in the United Kingdom, Germany, France, other European countries, the United States, Canada, Mexico, Japan, China, and internationally. Smiths Group plc was founded in 1851. The company was formerly known as Smiths Industries Ltd and changed its name to Smiths Group plc in 2000. The company is headquartered in London, the United Kingdom.

Key Statistics